Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;15(1):588-591.
doi: 10.3892/ol.2017.7285. Epub 2017 Oct 30.

Effective treatment of a patient with stage IV ovarian cancer: A case report

Zhen Huang  1 , Hua Yan  2 , Devendra Chavan  1 , Zeng Yuan  1 , Xingsheng Yang  1 , Youzhong Zhang  1 , Kun Song  1 , Beihua Kong  1
Affiliations

Effective treatment of a patient with stage IV ovarian cancer: A case report

Zhen Huang et al. Oncol Lett. 2018 Jan.

Abstract

The present case report describes a patient with stage IV ovarian cancer who survived for 9 years without achieving a complete remission since the first relapse. The patient's long-term survival may be ascribed to the slow growth of the cancer cells, limited metastasis and favorable responses to the treatments received. The patient manifested initially with malignant pleural effusion and was not able to tolerate surgical treatment. However, the disease was well-controlled using various treatments, including neoadjuvant chemotherapy, interval cytoreductive surgery and post-operative long-term chemotherapy. Management of ovarian cancer is most effective when tailored to the individual needs of the patient, maximizing its efficacy and prolonging the patient's survival rate. The present case may offer useful insight into the clinical management of stage IV ovarian cancer.

Keywords: interval cytoreductive surgery; neoadjuvant chemotherapy; ovarian neoplasms; post-surgery chemotherapy; treatment.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Levels of CA125 prior to and following treatment. CA125, cancer antigen 125.
See this image and copyright information in PMC

References

    1. Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. Ovarian cancer. Lancet. 2014;384:1376–1388. doi: 10.1016/S0140-6736(13)62146-7. - DOI - PubMed
    1. Narod S. Can advanced-stage ovarian cancer be cured? Nat Rev Clin Oncol. 2016;13:255–261. doi: 10.1038/nrclinonc.2015.224. - DOI - PubMed
    1. Davidson B, Tropé CG. Ovarian cancer: Diagnostic, biological and prognostic aspects. Womens Health (Lond) 2014;10:519–533. doi: 10.2217/WHE.14.37. - DOI - PubMed
    1. van der Burg ME, van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, Lacave AJ, Nardi M, Renard J, Pecorelli S. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological cancer cooperative group of the European organization for research and treatment of cancer. N Engl J Med. 1995;332:629–634. doi: 10.1056/NEJM199503093321002. - DOI - PubMed
    1. Redman CW, Warwick J, Luesley DM, Varma R, Lawton FG, Blackledge GR. Intervention debulking surgery in advanced epithelial ovarian cancer. Br J Obstet Gynaecol. 1994;101:142–146. doi: 10.1111/j.1471-0528.1994.tb13080.x. - DOI - PubMed